Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$100,000.00

Application of an in-vivo bioreactor as a biological platform for skin regeneration

FY 2011-12

Summary
In Canada, 10,000 patients are annually admitted due to sever thermal injuries. These patients require early wound coverage to survive. Currently, the treatment of choice is autografts, which has considerable limitations, such as lack of donor sites, especially in extensive burn patients. Therefore, the advancement towards engineered tissue will prove to be a tremendous asset for clinical practices in wound care. However, there are many methods to engineer tissue, one of these is using bioreactors. Bioreactors are able to create an ideal environment for the generation of tissue. Our group has recently developed a bioreactor that allows flow perfusion and sampling of the generated tissue as well as its fluid. Preliminary data has shown that adipocyte-derived stem cells (ASC) are able to improve healing in-vivo. The aim of this study is to use ASC in our in-vivo bioreactor to generate skin in a mouse model. Our hypothesis is that ASC may differentiate into skin in our in-vivo bioreactor. To achieve this, the tissue growth, cellular infiltration, angiogenesis and tissue perfusion in the in-vivo bioreactor will be evaluated. Also, differentiation of ASC to fibroblasts, keratinocytes and endothelial cells will be induced. Conditions of these differentiation processes will be optimized and applied into our in-vivo bioreactor model. Finally, tissue growth will be accelerated with the incorporation of nutrient-rich perfusates into our in-vivo bioreactor. The knowledge generated through the development of an in-vivo bioreactor plus the generation of skin tissue will set the stage for a new era of tissue engineering resulting in a novel paradigm for how to treat extensive burns and possible chronic wounds, which will translate into better quality of life for patients.
Program
CIHR Fellowship
Location
Illinois, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
242290
Name
Chavez-Munoz Claudia I
Region
Illinois
Country
United States of America
Orgtype
Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Application of an in-vivo bioreactor as a biological platform for skin regeneration
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adipocyte-Derived Stem Cells; Bioreactor Chamber; Burn Patients; Skin; Tissue Engineering; Tissue Regeneration; Wound Healing
Abstract
In Canada, 10,000 patients are annually admitted due to sever thermal injuries. These patients require early wound coverage to survive. Currently, the treatment of choice is autografts, which has considerable limitations, such as lack of donor sites, especially in extensive burn patients. Therefore, the advancement towards engineered tissue will prove to be a tremendous asset for clinical practices in wound care. However, there are many methods to engineer tissue, one of these is using bioreactors. Bioreactors are able to create an ideal environment for the generation of tissue. Our group has recently developed a bioreactor that allows flow perfusion and sampling of the generated tissue as well as its fluid. Preliminary data has shown that adipocyte-derived stem cells (ASC) are able to improve healing in-vivo. The aim of this study is to use ASC in our in-vivo bioreactor to generate skin in a mouse model. Our hypothesis is that ASC may differentiate into skin in our in-vivo bioreactor. To achieve this, the tissue growth, cellular infiltration, angiogenesis and tissue perfusion in the in-vivo bioreactor will be evaluated. Also, differentiation of ASC to fibroblasts, keratinocytes and endothelial cells will be induced. Conditions of these differentiation processes will be optimized and applied into our in-vivo bioreactor model. Finally, tissue growth will be accelerated with the incorporation of nutrient-rich perfusates into our in-vivo bioreactor. The knowledge generated through the development of an in-vivo bioreactor plus the generation of skin tissue will set the stage for a new era of tissue engineering resulting in a novel paradigm for how to treat extensive burns and possible chronic wounds, which will translate into better quality of life for patients.
Competitiondate
201110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Chavez-Munoz, Claudia I
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~
Direct Payment - $100,000 Grant (2011-12) | Canada Spends